JP Morgan Chase’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,900
Closed -$1.04M 7490
2025
Q4
$1.04M Hold
12,900
﹤0.01% 4584
2025
Q3
$1.26M Buy
+12,900
New +$1.04M ﹤0.01% 4419

Other funds holding ACLS

JP Morgan Chase's ACLS Position: Q1 2026 in Review

JP Morgan Chase reduced its Axcelis (ACLS) stake by 38% in Q1 2026, selling an estimated $11.9M and leaving 222,714 shares worth $20.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

JP Morgan Chase first reported a position in ACLS in Q2 2013 and has held it in 45 quarters since. The position peaked at $73.2M in Q4 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • JP Morgan Chase held 222,714 shares of Axcelis worth $20.1M as of Q1 2026.
  • JP Morgan Chase sold 134,788 Axcelis shares in Q1 2026, an estimated $11.9M.
  • Axcelis made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2063 holding.
  • JP Morgan Chase first reported a position in Axcelis in Q2 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's Axcelis position peaked at $73.2M in Q4 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.